BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 27545007)

  • 21. Clinical cytogenetics in pediatric acute leukemia: an update.
    Braoudaki M; Tzortzatou-Stathopoulou F
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):230-7. PubMed ID: 22609262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique.
    Romana SP; Radford-Weiss I; Ben Abdelali R; Schluth C; Petit A; Dastugue N; Talmant P; Bilhou-Nabera C; Mugneret F; Lafage-Pochitaloff M; Mozziconacci MJ; Andrieu J; Lai JL; Terre C; Rack K; Cornillet-Lefebvre P; Luquet I; Nadal N; Nguyen-Khac F; Perot C; Van den Akker J; Fert-Ferrer S; Cabrol C; Charrin C; Tigaud I; Poirel H; Vekemans M; Bernard OA; Berger R;
    Leukemia; 2006 Apr; 20(4):696-706. PubMed ID: 16467868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH).
    Decamp M; Klein E; Godon C; Lestringant V; Roynard P; Theisen O; Jimenez-Pocquet M; Roche-Lestienne C; Bidet A; Veronese L
    Curr Res Transl Med; 2023; 71(4):103424. PubMed ID: 38011761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia.
    Yang JJ; Park TS; Wan TS
    Methods Mol Biol; 2017; 1541():223-245. PubMed ID: 27910027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique.
    Gervais C; Murati A; Helias C; Struski S; Eischen A; Lippert E; Tigaud I; Penther D; Bastard C; Mugneret F; Poppe B; Speleman F; Talmant P; VanDen Akker J; Baranger L; Barin C; Luquet I; Nadal N; Nguyen-Khac F; Maarek O; Herens C; Sainty D; Flandrin G; Birnbaum D; Mozziconacci MJ; Lessard M;
    Leukemia; 2008 Aug; 22(8):1567-75. PubMed ID: 18528428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation. A report on 94 cases. Groupe Français de Cytogénétique Hématologique (GFCH).
    Hematol Cell Ther; 1996 Apr; 38(2):177-81. PubMed ID: 8931999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH).
    Lefebvre C; Veronese L; Nadal N; Gaillard JB; Penther D; Daudignon A; Chauzeix J; Nguyen-Khac F; Chapiro E
    Curr Res Transl Med; 2023; 71(4):103425. PubMed ID: 38016420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetics in the management of multiple Myeloma: The guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Daudignon A; Cuccuini W; Bracquemart C; Godon C; Quilichini B; Penther D
    Curr Res Transl Med; 2023; 71(4):103427. PubMed ID: 38035476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Nardi V; Hasserjian RP
    Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution.
    Hirsch P; Labopin M; Viguié F; Perot C; Isnard F; Mamez AC; Bilhou-Nabera C; Marzac C; Delhommeau F; Lapusan S; Marie JP; Mohty M; Legrand O
    Leuk Res; 2014 Aug; 38(8):907-12. PubMed ID: 24957411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
    Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
    Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.
    Breems DA; Van Putten WL; De Greef GE; Van Zelderen-Bhola SL; Gerssen-Schoorl KB; Mellink CH; Nieuwint A; Jotterand M; Hagemeijer A; Beverloo HB; Löwenberg B
    J Clin Oncol; 2008 Oct; 26(29):4791-7. PubMed ID: 18695255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current Knowledge.
    Quessada J; Cuccuini W; Saultier P; Loosveld M; Harrison CJ; Lafage-Pochitaloff M
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34204358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances of study on prognostic factors of molecular biology in acute myeloid leukemia with normal cytogenetics].
    Han TJ; Xu XP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1063-8. PubMed ID: 20723330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
    Lu Y; Xu W; Chen Z; Lou J; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.